Literature DB >> 27224028

Gadolinium in Humans: A Family of Disorders.

Richard C Semelka1, Miguel Ramalho1,2, Mamdoh AlObaidy1,3, Joana Ramalho1,4.   

Abstract

OBJECTIVE: The literature informs us that gadolinium can cause health issues. At least four major gadolinium disorders, including the two well-recognized nephrogenic systemic fibrosis and severe acute adverse event, have been identified.
CONCLUSION: We propose naming the histopathologically proven presence of gadolinium in brain tissue "gadolinium storage condition," and we describe a new entity that represents symptomatic deposition of gadolinium in individuals with normal renal function, for which we propose the designation "gadolinium deposition disease."

Entities:  

Keywords:  MRI; gadolinium; toxicity

Mesh:

Substances:

Year:  2016        PMID: 27224028     DOI: 10.2214/AJR.15.15842

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

Review 1.  Gadolinium retention in the body: what we know and what we can do.

Authors:  Enrico Tedeschi; Ferdinando Caranci; Flavio Giordano; Valentina Angelini; Sirio Cocozza; Arturo Brunetti
Journal:  Radiol Med       Date:  2017-03-30       Impact factor: 3.469

Review 2.  Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.

Authors:  Einat Blumfield; David W Swenson; Ramesh S Iyer; A Luana Stanescu
Journal:  Pediatr Radiol       Date:  2019-03-29

3.  Sensitivity of susceptibility-weighted imaging in detecting developmental venous anomalies and associated cavernomas and microhemorrhages in children.

Authors:  Allen Young; Andrea Poretti; Thangamadhan Bosemani; Reema Goel; Thierry A G M Huisman
Journal:  Neuroradiology       Date:  2017-06-30       Impact factor: 2.804

Review 4.  Evaluating the Patient with Reported Gadolinium-Associated Illness.

Authors:  Tatyana Lyapustina; Charlotte Goldfine; Sean Rhyee; Kavita M Babu; Matthew K Griswold
Journal:  J Med Toxicol       Date:  2018-11-29

Review 5.  A Review of the Current Evidence on Gadolinium Deposition in the Brain.

Authors:  Richard Pullicino; Mark Radon; Shubhabrata Biswas; Maneesh Bhojak; Kumar Das
Journal:  Clin Neuroradiol       Date:  2018-03-09       Impact factor: 3.649

6.  Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?

Authors:  Ezekiel Maloney; A Luana Stanescu; Francisco A Perez; Ramesh S Iyer; Randolph K Otto; Sarah Leary; Lotte Steuten; Amanda I Phipps; Dennis W W Shaw
Journal:  Pediatr Radiol       Date:  2018-05-22

7.  Collagenase-Cleavable Peptide Amphiphile Micelles as a Novel Theranostic Strategy in Atherosclerosis.

Authors:  Deborah D Chin; Christopher Poon; Noah Trac; Jonathan Wang; Jackson Cook; Johan Joo; Zhangjingyi Jiang; Naomi Sulit Sta Maria; Russell E Jacobs; Eun Ji Chung
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

8.  Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.

Authors:  Bronwyn E Hamilton; Ramon Barajas; Gary M Nesbit; Rongwei Fu; Prakash Ambady; Matthew Taylor; Edward A Neuwelt
Journal:  AJR Am J Roentgenol       Date:  2020-10-14       Impact factor: 3.959

Review 9.  Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families.

Authors:  Sakura M Noda; Murat Alp Oztek; A Luana Stanescu; Ezekiel Maloney; Dennis W W Shaw; Ramesh S Iyer
Journal:  Pediatr Radiol       Date:  2021-05-12

10.  Dynamic Serial Cytokine Measurements During Intravenous Ca-DTPA Chelation in Gadolinium Deposition Disease and Gadolinium Storage Condition: A Pilot Study.

Authors:  Holden T Maecker; Janet C Siebert; Yael Rosenberg-Hasson; Lorrin M Koran; Miguel Ramalho; Richard C Semelka
Journal:  Invest Radiol       Date:  2022-01-01       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.